Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
2.630
+0.040 (1.54%)
Sep 2, 2026, 4:00 PM EDT - Market closed
Compugen Employees
Compugen had 75 employees as of December 31, 2025. The number of employees increased by 1 or 1.35% compared to the previous year.
Employees
75
Change (1Y)
1
Growth (1Y)
1.35%
Revenue / Employee
$986,680
Profits / Employee
$469,213
Market Cap
249.12M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 75 | 1 | 1.35% |
| Dec 31, 2024 | 74 | 6 | 8.82% |
| Dec 31, 2023 | 68 | -1 | -1.45% |
| Dec 31, 2022 | 69 | -4 | -5.48% |
| Dec 31, 2021 | 73 | 5 | 7.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Entrada Therapeutics | 152 |
| Adagene | 128 |
| Invivyd | 122 |
| Niagen Bioscience | 117 |
| Neumora Therapeutics | 63 |
| Camp4 Therapeutics | 48 |
| Eledon Pharmaceuticals | 33 |
CGEN News
- 4 weeks ago - Compugen Earnings Call Transcript: Q2 2026 - Transcripts
- 4 weeks ago - Compugen Earnings release: Q2 2026 - Filings
- 4 weeks ago - Compugen reports Q2 EPS (7c), consensus (9c) - TheFly
- 4 weeks ago - Compugen Reports Second Quarter 2026 Results - PRNewsWire
- 4 weeks ago - Compugen Slides: Corporate presentation - Filings
- 6 weeks ago - Compugen to Participate in BTIG Biotechnology Conference 2026 - PRNewsWire
- 6 weeks ago - Compugen to Release Second Quarter 2026 Results on Monday, August 3, 2026 - PRNewsWire
- 7 weeks ago - Compugen management to meet virtually with Lake Street - TheFly